Biotechnology Services

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link

1 year ago

Illumina Names New Chief Executive

Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight…

1 year ago

Amgen's Deal for Horizon Therapeutics Clears Key Hurdle

The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact…

1 year ago

FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics

The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source…

1 year ago

Pfizer’s Covid Boost Crashes to Earth

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber…

2 years ago

The Political Turf Battle Over the Future of Your Prime Rib

The White House must decide whether the Food and Drug Administration or Agriculture Department will oversee the food-company scientists tweaking…

2 years ago

Biogen to Buy Reata in $7.3 Billion Deal

The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link

2 years ago

Biogen to Cut Roughly 11% of Workforce

The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link

2 years ago

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link

2 years ago

Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.

Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago.…

2 years ago